AIM
ATHN

Acrospire Investment Management’s Athenahealth, Inc. ATHN Stock Holding History

Acrospire Investment Management’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-200
Closed -$28K – 1907
2017
Q2 		$28K Hold
200
– – 0.03% 1334
2017
Q1 		$23K Sell
200
-800
-80% -$93.2K 0.02% 1558
2016
Q4 		$105K Buy
1,000
+500
+100% +$53.7K 0.04% 897
2016
Q3 		$63K Buy
500
+400
+400% +$50.9K 0.04% 899
2016
Q2 		$14K Buy
+100
New +$13.2K 0.01% 1665

Other funds holding ATHN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Acrospire Investment Management's ATHN Position: Q3 2017 in Review

Acrospire Investment Management sold out of Athenahealth, Inc. (ATHN) in Q3 2017, closing a stake of 200 shares — an estimated $28K sold.

Acrospire Investment Management first reported a position in ATHN in Q2 2016 and held it in 5 quarters. The position peaked at $105K in Q4 2016. 227 funds tracked by Wall St. Rank hold ATHN as of Q3 2017.

  • Acrospire Investment Management reported no remaining Athenahealth, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 200 Athenahealth, Inc. shares in Q3 2017, an estimated $28K.
  • Acrospire Investment Management first reported a position in Athenahealth, Inc. in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Athenahealth, Inc. position peaked at $105K in Q4 2016.
  • 227 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.